Om

Galmed Pharmaceuticals Ltd. is a clinical-stage biopharmaceutical company focused on developing therapies for liver, metabolic, and inflammatory diseases. Its current work centers on Aramchol, an oral drug candidate being studied for liver disease and related fibro-inflammatory conditions, alongside efforts to broaden its pipeline into cardiometabolic and gastrointestinal oncology indications. The company also pursues research collaborations, including work on peptide-based programs such as Amilo-5MER, to address unmet medical needs in areas where treatment options remain limited. Galmed Pharmaceuticals Ltd. serves as a specialized drug development platform, advancing candidates from discovery through clinical evaluation and targeting diseases that affect metabolism, liver function, and inflammation.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I GALMED PHARMACEUTICALS MED ENDAVU: Køb Galmed Pharmaceuticals ($GPH) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Galmed Pharmaceuticals, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.